Successful treatment of refractory pure red cell aplasia with eltrombopag after ABO-incompatible allogeneic hematopoietic stem cell transplantation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Successful treatment of refractory pure red cell aplasia with eltrombopag after ABO-incompatible allogeneic hematopoietic stem cell transplantation

Published:2021-07 Issue:8 Volume:22 Page:695-700
ISSN:1673-1581
Container-title:Journal of Zhejiang University-SCIENCE B
language:en
Short-container-title:J. Zhejiang Univ. Sci. B

Author:

Gao Yang,Gao Fei,Shi Jimin,Fu Huarui,Huang He^ORCID,Zhao Yanmin^ORCID

Funder

National Natural Science Foundation of China

the Health Science and Technology Project of Zhejiang Province,China

Publisher

Zhejiang University Press

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Veterinary,General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

https://link.springer.com/content/pdf/10.1631/jzus.B2000532.pdf

Reference16 articles.

1. Alvarado LJ, Huntsman HD, Cheng H, et al., 2019. Eltrombopag maintains human hematopoietic stem and progenitor cells under inflammatory conditions mediated by IFN-γ. Blood, 133(19):2043–2055. https://doi.org/10.1182/blood-2018-11-884486

2. Bao WL, Bussel JB, Heck S, et al., 2010. Improved regulatory T-cell activity in patients with chronic immune thrombocytopenia treated with thrombopoietic agents. Blood, 116(22):4639–4645. https://doi.org/10.1182/blood-2010-04-281717

3. Bathini S, Holtzman NG, Koka R, et al., 2019. Refractory postallogeneic stem cell transplant pure red cell aplasia in remission after treatment with daratumumab. Am J Hematol, 94(8):E216–E219. https://doi.org/10.1002/ajh.25515

4. Busca A, Dellacasa C, Giaccone L, et al., 2018. Eltrombopag for the treatment of refractory pure RBC aplasia after major ABO incompatible hematopoietic stem cell transplantation. Biol Blood Marrow Transplant, 24(8):1765–1770. https://doi.org/10.1016/j.bbmt.2018.04.022

5. Desmond R, Townsley DM, Dumitriu B, et al., 2014. Eltrombopag restores trilineage hematopoiesis in refractory severe aplastic anemia that can be sustained on discontinuation of drug. Blood, 123(12):1818–1825. https://doi.org/10.1182/blood-2013-10-534743

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pure Red Cell Aplasia - Post Major ABO Incompatible Allogenic Stem Cell Transplantation Role of Ibrutinib;Journal of Stem Cell Therapy and Transplantation;2024-07-24

2. Pure red cell aplasia among ABO mismatched hematopoietic stem cell transplant recipients: a 13-years retrospective study and literature review;Frontiers in Oncology;2024-07-02

3. Successful treatment pure red cell aplasia after ABO major mismatched allogeneic hematopoietic stem cell transplantation with avatrombopag and low dose rituximab;Transfusion;2024-02-13

4. Non-prise de greffe, dysfonctionnement du greffon et érythroblastopénie : mise à jour des définitions, outils diagnostiques et prise en charge : recommandation de la SFGM-TC;Bulletin du Cancer;2023-02

5. Pure red cell aplasia after hematopoietic stem cell transplantation - experimental therapeutic approaches;Expert Opinion on Investigational Drugs;2022-09-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3